Loading...
NPI 1396733945 · Columbus, MS · Ambulatory Surgical Clinic/Center
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Eye Laser & Surgery Center Of Columbus, LLC is a ambulatory surgical clinic/center provider located in Columbus, Mississippi. This profile covers 5 Medicare and 4 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Eye Laser & Surgery Center Of Columbus, LLC |
| Address | 634 Leigh Dr |
| City | Columbus |
| State | MS |
| ZIP | 39705 |
| Taxonomy | Ambulatory Surgical Clinic/Center |
| NPI Enumerated | October 7, 2005 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $1.5M |
| Medicaid | $293.8K |
This entity is an ambulatory surgical clinic/center whose Medicare billing is dominated by cataract surgery and related intraoperative ophthalmic medications and inserts. The top three Medicare lines are 66984, J1097, and J1096 and together account for 90.7% of the provider's total Medicare revenue; average Medicare paid/claim for those lines are reported as $726 (66984), $76 (J1097), and $100 (J1096), which aligns with a procedure-focused cataract surgery practice that also bills intraoperative irrigation and steroid insert products.
Revenue concentration is high across both payers: the precomputed top-3 Medicare codes explain 90.7% of Medicare revenue and the top-3 Medicaid codes explain 100.0% of Medicaid revenue. That concentration indicates the business is heavily dependent on a narrow set of cataract-related services for its reimbursement streams, increasing sensitivity to pricing or utilization changes specific to those codes.
Medicaid billing is effectively single-procedure: 66984 is listed at $293.9K and represents 100.0% of the provider's Medicaid revenue lines in the dataset. By contrast the facility's total Medicaid revenue is reported as $293.8K while total Medicare revenue is $1.5M, so Medicare constitutes the materially larger share of billed government payer dollars for this provider.
On Medicare competitive standing the provider shows respectable but not dominant national placement for its top codes: 66984 ranks #1843 of 15965 providers (88th percentile; typical, unremarkable volume), J1097 ranks #68 of 443 (85th percentile; typical, unremarkable volume), and J1096 ranks #29 of 282 (90th percentile; typical, unremarkable volume). These percentiles indicate the center operates at solid volume for its specialty compared with national peers, but the reporting labels characterize the volumes as typical rather than outlier-level.
Within-state competitiveness for Medicaid cataract surgery is notable but not leading: Medicaid 66984 ranks #10 of 42 providers in-state (78th percentile; typical, unremarkable volume). That placement suggests the center is an established regional provider of cataract extraction services to Medicaid patients, concentrated on the same core surgical procedure it bills to Medicare.
Operational billing patterns include some lines with claims but no associated Medicaid payments: G8907 (604 claims) and J1097 (39 claims) are reported with $0 average paid/claim and $0 revenue despite appearing on Medicaid claim counts. Separately, C9447 appears with minimal Medicaid reimbursement ($2 avg paid/claim, $100 revenue), underscoring that most Medicaid dollars flow through the primary surgical code rather than ancillary supply codes.
Tenure data show the provider has an active NPI enumerated on 2005-10-07 (~21 years ago), indicating a long-standing presence in the market that aligns with its procedure-focused surgical profile and the consistent high-volume reporting on a small set of ophthalmic surgery codes.
From a payer-mix and service-line perspective, the dataset describes a specialty ambulatory surgical center with a stable cataract surgery franchise: Medicare ($1.5M) drives most revenue while Medicaid ($293.8K) supports a smaller but concentrated caseload almost entirely coded to 66984. Analysts should consider that business risk and growth opportunities for this center are likely tied to cataract surgery volume, intraoperative medication utilization, and reimbursements for the specific device/insert products reflected in J1097 and J1096.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
5 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 66984 | The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to… | 1,140 | $730 | $826.9K |
| J1097 | phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml | 3,800 | $80 | $288.8K |
| J1096 | Dexamethasone, lacrimal ophthalmic insert, 0.1 mg | 2,810 | $100 | $281.2K |
| 66991 | The provider inserts an intraocular lens prosthesis during the same session as extracapsular cataract extraction. The provider also inserts one or more anterior segment aqueous drainage devices in… | 50 | $2,200 | $108K |
| 65820 | The provider incises the limbus to improve drainage of aqueous humor in the eye. This procedure is typically performed on children, usually to treat congenital glaucoma. | 30 | $1,100 | $35.2K |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 5 CPT/HCPCS codes.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
4 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 66984 | The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to… | 1,520 | $190 | $293.9K |
| C9447 | Injection, phenylephrine and ketorolac, 4 ml vial | 50 | $1 | $100 |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer… | 600 | $0 | $0 |
| J1097 | phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml | 40 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other Mississippi providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Mississippi median
4 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 66984 | The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to… | 10 | 40 | 300 | $180 | $191.9K |
| J1097 | phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml | 9 | 10 | 190 | $20 | $12.9K |
| C9447 | Injection, phenylephrine and ketorolac, 4 ml vial | 6 | 10 | 130 | $10 | $1.9K |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer… | 26 | 60 | 520 | $1 | $200 |
Other providers in the same ZIP code as Eye Laser & Surgery Center Of Columbus, LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.